F. Caussade

613 total citations
19 papers, 452 citations indexed

About

F. Caussade is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, F. Caussade has authored 19 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Organic Chemistry and 7 papers in Physiology. Recurrent topics in F. Caussade's work include Pain Mechanisms and Treatments (5 papers), Receptor Mechanisms and Signaling (4 papers) and Neuropeptides and Animal Physiology (4 papers). F. Caussade is often cited by papers focused on Pain Mechanisms and Treatments (5 papers), Receptor Mechanisms and Signaling (4 papers) and Neuropeptides and Animal Physiology (4 papers). F. Caussade collaborates with scholars based in France, United States and Germany. F. Caussade's co-authors include Alain Eschalier, A. Cloarec, Jean‐Philippe Courade, Naı̈ma Hanoun, D. Besse, M. Hamon, J Lavarenne, Abdelkrim Alloui, Claude Dubray and Teresa Pélissier and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

F. Caussade

19 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Caussade France 11 179 104 101 101 89 19 452
A. Cloarec France 9 118 0.7× 92 0.9× 88 0.9× 59 0.6× 126 1.4× 18 440
Gregor Vetter Germany 11 175 1.0× 108 1.0× 221 2.2× 103 1.0× 31 0.3× 15 562
Filomena Lauro Italy 13 263 1.5× 201 1.9× 49 0.5× 88 0.9× 20 0.2× 20 568
M J Daly United Kingdom 14 103 0.6× 209 2.0× 77 0.8× 116 1.1× 23 0.3× 30 524
M. Marietta United States 12 55 0.3× 110 1.1× 104 1.0× 93 0.9× 13 0.1× 22 481
Per Juul Denmark 13 96 0.5× 143 1.4× 137 1.4× 103 1.0× 49 0.6× 44 634
Kathryn W. Schenck United States 13 200 1.1× 314 3.0× 62 0.6× 238 2.4× 75 0.8× 25 672
Mary K. Grizzle United States 17 99 0.6× 264 2.5× 31 0.3× 198 2.0× 102 1.1× 22 609
H Aihara Japan 11 65 0.4× 105 1.0× 64 0.6× 70 0.7× 33 0.4× 45 377
William B. Wastila United States 13 88 0.5× 225 2.2× 63 0.6× 106 1.0× 43 0.5× 28 589

Countries citing papers authored by F. Caussade

Since Specialization
Citations

This map shows the geographic impact of F. Caussade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Caussade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Caussade more than expected).

Fields of papers citing papers by F. Caussade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Caussade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Caussade. The network helps show where F. Caussade may publish in the future.

Co-authorship network of co-authors of F. Caussade

This figure shows the co-authorship network connecting the top 25 collaborators of F. Caussade. A scholar is included among the top collaborators of F. Caussade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Caussade. F. Caussade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Grégoire, Stéphanie, et al.. (2011). New method to discriminate sedative and analgesic effects of drugs in the automated formalin test in rats. Neuroscience Research. 72(2). 194–198. 7 indexed citations
3.
Potin, Dominique, Eric Nicolaï, F. Caussade, et al.. (2005). De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold. Bioorganic & Medicinal Chemistry Letters. 15(4). 1161–1164. 12 indexed citations
4.
Courade, Jean‐Philippe, F. Caussade, D. Besse, et al.. (2001). Effects of acetaminophen on monoaminergic systems in the rat central nervous system. Naunyn-Schmiedeberg s Archives of Pharmacology. 364(6). 534–537. 69 indexed citations
5.
Courade, Jean‐Philippe, D. Besse, Naı̈ma Hanoun, et al.. (2001). Acetaminophen distribution in the rat central nervous system. Life Sciences. 69(12). 1455–1464. 72 indexed citations
6.
Potin, Dominique, et al.. (2000). Novel 3-(4-piperidinylthio)-1H-indoles as potent nonopioid orally active central analgesics. Bioorganic & Medicinal Chemistry Letters. 10(8). 805–809. 15 indexed citations
7.
Courteix, Christine, Philippe Bourget, F. Caussade, et al.. (1998). Is the Reduced Efficacy of Morphine in Diabetic Rats Caused by Alterations of Opiate Receptors or of Morphine Pharmacokinetics?. Journal of Pharmacology and Experimental Therapeutics. 285(1). 63–70. 65 indexed citations
8.
Virone-Oddos, Angéla, et al.. (1997). In vitro and in vivo effects of UP 269‐6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation. British Journal of Pharmacology. 120(3). 488–494. 12 indexed citations
9.
Pélissier, Teresa, Abdelkrim Alloui, F. Caussade, et al.. (1996). Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence.. Journal of Pharmacology and Experimental Therapeutics. 278(1). 8–14. 92 indexed citations
10.
Nicolaï, Eric, et al.. (1995). Synthesis and angiotensin II receptor antagonist activity of C-linked pyrimidine derivatives. European Journal of Medicinal Chemistry. 30(5). 365–375. 7 indexed citations
11.
Caussade, F., et al.. (1995). In vitropharmacological characterization of UP 269‐6, a novel nonpeptide angiotensin II receptor antagonist. Fundamental and Clinical Pharmacology. 9(2). 119–128. 4 indexed citations
12.
Nicolaï, Eric, et al.. (1994). Synthesis and Angiotensin II Receptor Antagonist Activity of C-Linked Pyrazole Derivatives.. Chemical and Pharmaceutical Bulletin. 42(8). 1617–1630. 10 indexed citations
13.
Nicolaï, Eric, et al.. (1994). Synthesis and SAR Studies of Novel Triazolopyrimidine Derivatives as Potent, Orally Active Angiotensin II Receptor Antagonists. Journal of Medicinal Chemistry. 37(15). 2371–2386. 23 indexed citations
14.
Güngör, Timur, et al.. (1994). N6-Substituted Adenosine Receptor Agonists. Synthesis and Pharmacological Activity as Potent Antinociceptive Agents. Journal of Medicinal Chemistry. 37(25). 4307–4316. 19 indexed citations
15.
Nicolaï, Eric, et al.. (1993). Synthesis and structure-activity relationships of novel benzimidazole and imidazo[4,5-b]pyridine acid derivatives as thromboxane A2 receptor antagonists. Journal of Medicinal Chemistry. 36(9). 1175–1187. 27 indexed citations
16.
Caussade, F. & Alix Cloarec. (1993). Effect of tienoxolol, a new diuretic β‐blocking agent, on urinary prostaglandin excretion in the rat. British Journal of Pharmacology. 109(1). 278–284. 2 indexed citations
17.
Caussade, F., et al.. (1993). Synthesis and activities of new arylsulfonamido thromboxane A2 receptor antagonists. European Journal of Medicinal Chemistry. 28(7-8). 625–632. 6 indexed citations
18.
TEULON, J. M., et al.. (1993). ChemInform Abstract: Synthesis and Activities of New Arylsulfonamido Thromboxane A2 Receptor Antagonists.. ChemInform. 24(52). 1 indexed citations
19.
Caussade, F., et al.. (1991). Pharmacological profile of UP 5145-52, an original antiulcer and antisecretory agent.. Journal of Pharmacology and Experimental Therapeutics. 259(1). 190–197. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Cloarec Breakdown of academic impact, for papers by Gregor Vetter Breakdown of academic impact, for papers by Filomena Lauro Breakdown of academic impact, for papers by M J Daly Breakdown of academic impact, for papers by M. Marietta Breakdown of academic impact, for papers by Per Juul Breakdown of academic impact, for papers by Kathryn W. Schenck Breakdown of academic impact, for papers by Mary K. Grizzle Breakdown of academic impact, for papers by H Aihara Breakdown of academic impact, for papers by William B. Wastila
Rankless by CCL
2026